
    
      Cerebral cavernous malformation Patients with newly diagnosed, cerebral cavernous
      malformation who will visit one of the study centers during the period from June 2016 to
      December 2017. Patients would be eligible for enrollment if they were 18 years of age or
      older and had at least 1 cerebral cavernous malformation. If the patient had multiple
      cavernous malformations, index cavernous malformation would be enrolled. Index lesion will be
      determined according to the criteria.

        -  Index lesion decision criteria I. Symptomatic II. Asymptomatic (priorities are as
           follows)

             1. Previous bleed

             2. Brain stem location

             3. Deep nuclei (thalamus, caudate, basal ggl, hypothalamus)

             4. Periventricular

             5. Largest

      All patients who would visit a study center during the enrollment period and meet these
      criteria will be asked to join the study. The cohort will consists of patients who agree to
      participate. Target population of this study is 228 patients.
    
  